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Abstract: PURPOSE The management of severe soft tissue injuries to the extremities with full-thickness
wounds poses a challenge to the patient and surgeon. Dermal substitutes are used increasingly in these
defects. The aim of this study was to investigate the impact of the type of injury on the success rate
of Matriderm® (MD)-augmented split-thickness skin grafting, as well as the role of negative pressure
wound therapy (NPWT) in preconditioning of the wounds, with a special focus on the reduction of the
bioburden. METHODS In this study, 45 wounds (44 affecting lower extremities (97.7%)), resulting from
different types of injuries: soft tissue (ST), soft tissue complications from closed fracture (F), and open
fracture (OF) in 43 patients (age 55.0 ± 18.2 years, 46.7% female), were treated with the simultaneous
application of MD and split-thickness skin grafting. The study was designed as a retrospective cohort
study from March 2013 to March 2020. Patients were stratified into three groups: ST, F, and OF.
Outcome variables were defined as the recurrence of treated wound defects, which required revision
surgery, and the reduction of bioburden in terms of reduction of number of different bacterial strains. For
statistical analysis, Student’s t-test, analysis of variance (ANOVA), Mann-Whitney U test, and Pearson’s
chi-squared test were used. RESULTS There was no significant difference in the rate of recurrence in
the different groups (F: 0%; OF: 11.1%; ST: 9.5%). The duration of VAC therapy significantly differed
between the groups (F: 10.8 days; OF: 22.7 days; ST: 12.6 days (p < 0.05)). A clinically significant
reduction of bioburden was achieved with NPWT (bacterial shift (mean (SD), F: - 2.25 (1.89); OF: - 1.9
(1.37); ST: - 2.6 (2.2)). CONCLUSION MD-augmented split-thickness skin grafting is an appropriate
treatment option for full-thickness wounds with take rates of about 90%. The complexity of an injury
significantly impacts the duration of the soft tissue treatment but does not have an influence on the
take rate. NPWT leads to a relevant reduction of bioburden and is therefore an important part in the
preconditioning of full-thickness wounds.
DOI: https://doi.org/10.1007/s00423-021-02224-7






The following work is licensed under a Creative Commons: Attribution 4.0 International (CC BY 4.0)
License.
Originally published at:
Lempert, Maximilian; Halvachizadeh, Sascha; Salfelder, Clara Charlotte; Neuhaus, Valentin; Pape, Hans-
Christoph; Jukema, Gerrolt Nico (2021). Long-term experience with a collagen-elastin scaffold in combi-
nation with split-thickness skin grafts for the treatment of full-thickness soft tissue defects: improvements




Langenbeck’s Archives of Surgery 
https://doi.org/10.1007/s00423-021-02224-7
ORIGINAL ARTICLE
Long‑term experience with a collagen‑elastin scaffold in combination 
with split‑thickness skin grafts for the treatment of full‑thickness soft 
tissue defects: improvements in outcome—a retrospective cohort 
study and case report
Maximilian Lempert1  · Sascha Halvachizadeh1 · Clara Charlotte Salfelder1 · Valentin Neuhaus1 · 
Hans‑Christoph Pape1 · Gerrolt Nico Jukema1
Received: 24 July 2020 / Accepted: 1 June 2021 
© The Author(s) 2021
Abstract
Purpose The management of severe soft tissue injuries to the extremities with full-thickness wounds poses a challenge to 
the patient and surgeon. Dermal substitutes are used increasingly in these defects. The aim of this study was to investigate 
the impact of the type of injury on the success rate of Matriderm® (MD)-augmented split-thickness skin grafting, as well as 
the role of negative pressure wound therapy (NPWT) in preconditioning of the wounds, with a special focus on the reduc-
tion of the bioburden.
Methods In this study, 45 wounds (44 affecting lower extremities (97.7%)), resulting from different types of injuries: soft 
tissue (ST), soft tissue complications from closed fracture (F), and open fracture (OF) in 43 patients (age 55.0 ± 18.2 years, 
46.7% female), were treated with the simultaneous application of MD and split-thickness skin grafting. The study was 
designed as a retrospective cohort study from March 2013 to March 2020. Patients were stratified into three groups: ST, F, 
and OF. Outcome variables were defined as the recurrence of treated wound defects, which required revision surgery, and 
the reduction of bioburden in terms of reduction of number of different bacterial strains. For statistical analysis, Student’s 
t-test, analysis of variance (ANOVA), Mann–Whitney U test, and Pearson’s chi-squared test were used.
Results There was no significant difference in the rate of recurrence in the different groups (F: 0%; OF: 11.1%; ST: 9.5%). 
The duration of VAC therapy significantly differed between the groups (F: 10.8 days; OF: 22.7 days; ST: 12.6 days (p < 0.05)). 
A clinically significant reduction of bioburden was achieved with NPWT (bacterial shift (mean (SD), F: − 2.25 (1.89); 
OF: − 1.9 (1.37); ST: − 2.6 (2.2)).
Conclusion MD-augmented split-thickness skin grafting is an appropriate treatment option for full-thickness wounds with 
take rates of about 90%. The complexity of an injury significantly impacts the duration of the soft tissue treatment but does 
not have an influence on the take rate. NPWT leads to a relevant reduction of bioburden and is therefore an important part 
in the preconditioning of full-thickness wounds.
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Introduction
The management of complex injuries to the extremities 
with full-thickness wounds poses a challenge to the sur-
geon. In many cases, the wound will heal with some sort 
of defects compromising functionality and cosmetics [1]. 
When primary closure is not feasible, more complex pro-
cedures such as split-thickness skin grafts or even fascio-
cutaneous/microvascular free flaps will be necessary. The 
split-thickness skin grafts often only provide unsatisfac-
tory results in terms of mechanical stability, flexibility, 
and cosmetics due to insufficient underlying dermal tis-
sue [2–6], while flap surgery is a more complex proce-
dure with higher risks of complications and morbidity at 
acceptor side as well as donor side. Moreover, a dedicated 
plastic surgery department is not widely available in most 
regional hospitals [2].
Hence, dermal substitutes functioning as a matrix replacing 
the subcutaneous tissue have been proposed and further devel-
oped as a treatment of choice for full-thickness wounds where 
split-thickness skin grafts must be used [7].
One of those substitutes is Matriderm® matrix (Med-
skin Dr. Suwelack Skin & Health Care AG, Billerbeck, 
Germany), which is of bovine origin and provides an elas-
tic and stable neo-dermis formed by a three-dimensional 
matrix consisting of collagen types I, III, and V, addi-
tionally supplemented by elastin hydrolysate [6–8]. The 
resulting product exhibits a thickness of 1.0 mm, allowing 
for a single-step combination [4] with an autologous skin 
graft (nutritional supply by diffusion limiting maximum 
thickness and distance to the wound base). Within several 
weeks, this matrix is then replaced by endogenous colla-
gen leading to superior results compared to split-thickness 
skin grafts alone [6]. There are several reports of success-
ful engraftment in a one-step procedure using Matriderm® 
and split skin grafting both in vitro [9] and in vivo [3, 10, 
11] as well as in clinical trials [12–15].
In complex wounds, conditioning with negative pres-
sure wound therapy (NPWT) prior to definitive closure 
is often necessary [16]. NPWT involves the delivery of 
negative pressure through a vacuum pump maintaining 
a closed environment. NPWT increases perfusion, pro-
motes granulation tissue formation, and reduces edema 
and the bacterial load [17, 18]. By this, the size of the 
defect can be significantly reduced, further reducing mor-
bidity at the donor as well as the acceptor side in wounds 
treated with autologous skin grafting [19]. Furthermore, 
the reduction of the bioburden through NPWT is an impor-
tant contribution to the conditioning of wounds leading to 
improvements in outcome [20]. Additionally, postopera-
tive epicutaneous NPWT has been proven to increase the 
take rate of skin grafts as it protects the graft from the 
environment, therefore reducing the risk of infection and 
detachment. Furthermore, the negative pressure is said to 
speed up vascularization and thereby further improving 
the take rate [21].
In our study, we aimed to investigate the impact of the 
complexity of wounds on the success of Matriderm®-
augmented split-thickness skin grafts as well as the role of 
NPWT in the preconditioning of the defects with a focus on 
its impact on the development of the bacterial load during 
the course of the treatment.
Patients and methods
This monocentric retrospective cohort study was conducted 
at an academic level 1 trauma center in Switzerland between 
March 2013 and March 2020. The study was carried out in 
accordance with the local institutional ethics committee’s 
terms of reference (Kantonale Ethikkommission Zürich, 
Switzerland (approval number PB-2016–01,888)). Regular 
follow-ups were performed at our outpatient clinic usually 
starting 2 weeks after dismissal of the patient. Follow-up 
was discontinued at the earliest 1 year posttraumatic unless 
a patient was lost for follow-up before that. Data collec-
tion—based on in hospital electronic documentation sys-
tems—begun with admission of the patient and was updated 
during surgical procedures. Patient-specifics and demo-
graphic characteristics as well as type of injury and body 
region of wound defect were documented. Data was then 
collected by two authors (ML, CS). We extracted the fol-
lowing parameters:
(i) Patient characteristics (age, gender, comorbidities)
(ii) Injury (location, size, type of injury (soft tissue, frac-
ture, open fracture))
(iii) Treatment (time of NPWT, NPWT changes, duration 
of stay)
(iv) Microbiology (bacterial growth, antibiotics given)
(v) Outcome variables (rate of recurrence, reduction of 
bioburden)
The study was conducted and reported according to the 
STROBE guidelines [22].
Eligibility criteria included an age of over 16 years and 
performance of Matriderm®-augmented split-thickness skin 
grafting in a full-thickness wound in a one-step approach 
with subsequent epicutaneous NPWT for at least 5 days post-
surgery and a follow-up period of at least 8 weeks. Patients 
were stratified into 3 different groups according to the type 
of injury (fracture; open fracture; soft tissue injury). The 
standard treatment protocol for wounds, which could not be 
covered with Matriderm®-augmented skin grafting due to 
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local inflammation or contamination on the day of admission, 
included multiple surgical debridements, irrigation, and 
temporary closure with NPWT using a PVA or a PUE foam 
(Kinetic Concepts Inc. (KCI), San Antonio, TX, USA) prior 
to the Matriderm®-augmented split-skin-graft procedure. All 
patients with proven or suspected local infection as well as 
patients with high risk for infection (e.g., patients with open 
fractures) were initially treated with an intravenous broad-
spectrum antibiotic (mostly amoxicillin/clavulanic acid). 
Antibiotic therapy was then changed based on the antibacterial 
sensitivity tests as soon as available. Patients without increased 
risk for infection (e.g., clean cut wounds) received an antibiotic 
single-shot prophylaxis (cefazolin) 30  min before every 
surgical intervention. Microbiological samples were taken 
during the first debridement, periodically during the sequential 
interventions, and when definitive closure was performed.
When the wounds showed sufficient granulation tissue 
and clinical signs of local inflammation (heat, pain, red-
ness, swelling, and loss of function) were absent, surgical 
coverage of the defects with a combination of Matriderm® 
matrix and split-thickness skin grafting was performed in a 
sterile operating theater by an experienced surgeon. Positive 
bacterial samples without clinical signs of infection did not 
necessarily lead to delaying definitive wound closure.
Surgical approach
After preparation of the wound, a Matriderm ® layer of 1.0 mm 
thickness was carefully cut to fit the size of the defect, with 
emphasis on avoiding oversizing. Proper positioning ensured 
full contact to the underlying soft tissue (wound base). Immedi-
ate soaking of the matrix indicated adequate placement. After 
harvesting a skin graft of 0.3–0.5 mm, it was meshed according 
to the size of the defect (regular 1:1.5 or 1:3) and accurately 
placed on the Matriderm® layer. The graft was then fixed with 
single resorbable stitches and covered with a NPWT dressing 
with a silicon protection layer (Mepithel® (Mölnlycke Health 
Care AG, Brandstrasse 24, 8952, Schlieren, CH)) in between 
the mesh graft and the foam dressing. First dressing changes 
were regularly performed on the fifth day post-surgery. The site 
of skin graft harvest was covered with a combination of an algi-
nate and polyurethane foam adhesive dressing, which was left 
in place for 7 days.
The incidence of readmissions of included patients due 
to local complications, which required revision surgery, was 
recorded. Furthermore, the time between first debridement 
and wound closure as well as number of interventions prior the 
wound closure was recorded. Special focus was further put on 
length of stay (LOS) and the development of the bacterial spec-
trum. Additionally, the presence of diabetes mellitus, peripheral 
vascular disease (PVD), smoking, alcohol/drug abuse, and an 
immunodeficiency (human immunodeficiency virus (HIV) and 
malignancy) or immunosuppressive medication was noted, as 
they might impact the wound healing process.
Statistical analysis
Continuous data are presented with mean ± standard deviation 
(SD). Categorical variables are summarized as number and 
percentages. Normally distributed continuous variables were 
compared using Student’s t-test; group comparisons with more 
than two groups were performed with ANOVA. Skewed distrib-
uted comparisons were performed using Mann–Whitney U test. 
Pearson chi-square test was used for comparison of groups on 
discrete variables. The statistical analyses were performed using 
R (R Core Team (2018). R: A language and environment for 
statistical computing. R Foundation for Statistical Computing, 
Vienna, Austria. URL https:// www.R- proje ct. org/.)
Results
Between December 2012 and March 2020, we treated 43 
patients with a total of 45 soft tissue defects at our level 1 
trauma center with Matriderm®-augmented split skin graft-
ing in a one-step approach. Out of 45 treated defects, 44 
(97.7%) were located on the lower extremity. The demo-
graphics of our study are depicted in Table 1.
We screened all patients for comorbidities. Fifteen 
patients (34.8%) had none, while 28 patients (65.1%) had 
one to three relevant comorbidities. There was no significant 
difference between the three injury groups, nor did we find 
a relevant impact on the rate of recurrences.
The number of recurrences according to type of injury is 
shown in Table 2. In 39 (90.7%) out of 43 patients, we could 
Table 1  Demographics
n (cases) 45
Age (mean (SD)) 54.4 (18.72)
Female (%) 21 (46.7)
Closed fracture (%) 6 (13.3)
Open fracture (%) 18 (40.0)
Soft tissue (%) 21 (46.7)
Gustillo-Anderson classification of open fractures
  II 3 (16.7)
  IIIA 10 (55.6)
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achieve sufficient wound closure with the first Matriderm®-
augmented skin graft. The closed fracture group had no 
reoccurrence of the treated defect, while both the open frac-
ture group and the soft tissue group both had recurrences in 
2 patients, who required revision surgery.
Forty-three out of 45 (95.5%) wounds (cases) were treated 
with NPWT for variable periods of time before the perfor-
mance of Matriderm®-augmented split skin grafting. We 
stratified the duration of treatment according to three dif-
ferent types of injuries. Cases with open fractures required 
NPWT significantly longer than those with closed fractures 
or soft tissue defects without osseous involvement prior 
to the closure of the defect (Table 3). Furthermore, those 
cases being treated with V.A.C Ultra™ (V.A.C. Instilla-
tion™) therapy with diluted polyhexamethylene biguanide 
(PHMB) solution required NPWT significantly longer than 
those receiving regular NPWT (13.9 vs. 20.6 days).
The number of VAC—changes before the Matriderm@-
augmented split skin grafting procedure stratified to injury 
pattern—differed significantly between the different types of 
injuries. Patients with open fractures underwent a mean of 
4.9 changes while the ones with closed fractures underwent 
2.5 and those with only soft tissue injuries 2.9 procedures 
(p < 0.05) until the final wound closure with Matriderm®-
augmented split skin grafting was performed (Table 4).
The number of changes in the antibiotic treatment in rela-
tion to the injury type also showed clear differences. Patients 
with open fractures received a mean of 3.2 different antibi-
otic substances compared to 3 in the fracture group and 2.7 
in the soft tissue group.
The length of stay was also impacted by the type of injury 
causing the treated wound defect. Patients with underlying 
open fractures were hospitalized for 48.2 days compared to 
43.5 days in the soft tissue group. Patients with underlying 
closed fractures were hospitalized for 29.5 days on average 
(Table 5).
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When comparing the bacterial load found in the first 
debridement of the wounds and the bacterial load on the 
day of definitive wound closure, a clear trend of reduction 
can be seen (Table 6).
Case report
A 24-year-old man sustained a severe crush injury to the 
right lower limb in a forklift accident. The patient presented 
with an open femur fracture (Gustilo-Anderson Type IIIC, 
Picture 1) with severe comminution and subtotal amputation 
of the thigh and severe damage to the sciatic nerve. Further-
more, he sustained a substantial soft tissue defect in the right 
gluteal area with a foreign body in situ. The CT-angiogram 
showed a traumatic disruption of the distal superficial femo-
ral artery. Subsequently, the patient developed an ischemic 
compartment syndrome in the right lower leg and foot that 
required fasciotomy.
On the day of admission, we performed the implanta-
tion of an Omniflow® (LeMaitre Vascular, Inc., Burlington, 
MA, USA) vascular prosthesis (6 mm) from the disrupted 
superficial femoral artery to popliteal artery (end-to-end) 
with external fixator fixation of the fracture with shortening 
of the femur for 4 cm to reduce the tension of the soft tissue, 
including the sciatic nerve. Bilateral dermatofasciotomy of 
the lower leg and foot was performed in combination with 
debridement of the bone and soft tissue. After an extended 
lavage, NPWT for temporary occlusion of all wounds was 
applied. The soft tissue defect on the medial side of the thigh 
resulting from the OF was treated with regular NPWT for a 
total of 31 days. The vacuum dressings were consecutively 
changed (a total of eight times) in the operating theater in 
combination with recurrent lavage and surgical debridement. 
We applied white PVA dressings to the wound and covered 
them each time with a second foam layer on top of black PU 
dressings. After 31 days of NPWT, the defect was covered 
in a one-step procedure with 1-mm MD augmentation and 
a split-thickness mesh graft. The bacterial cultures of the 
patient showed multiple bacterial specimens (Stenotropho-
monas maltophilia, Bacillus cereus, and Staphylococcus 
epidermidis), which we treated according to the bacterial 
sensitivity with various combinations of different antibiotics 
(amoxicillin/clavulanic acid, clindamycin, vancomycin, and 
levofloxacin). When the split-thickness skin graft was per-
formed, the patient had two clean swabs from the previous 
dressing changes in a row and was under oral antimicrobial 
therapy with levofloxacin, which was applied as suppression 
therapy for a total of 442 days (Picture 2).
The MD-augmented mesh graft showed excellent healing 
with good functionality, stability, and elasticity (Picture 3).
The soft tissues, which were covered 3.5 years prior with 
mesh graft and MD augmentation, continued to be intact and 
free of irritation with good functionality until today.
Discussion
To our best knowledge, we report one of the largest cohorts 
of soft tissue defects treated with split skin grafts aug-
mented with a non-cross-linked collagen-elastin matrix 
(Matriderm®) for wound closure. In our clinic, we achieved 
promising results with the combination of split skin grafts 
and this dermal substitute in a one-step approach in com-
plex soft tissue defects, which is in accordance with the cur-
rent literature. We could achieve wound healing in 90.7% 
of the patients with the first approach, which is in accord-
ance with the findings of other groups [3, 10, 11]. We had 
a total of 5 recurrences of soft tissue defects (11.1%) in 4 
patients (9.3%). In one of those cases, there was an ongoing 
































Table 6  Bacterial shift stratified 
to injury type
F OF S p
n_bac_first (mean (SD)) 2.33 (1.97) 1.38 (1.59) 1.94 (2.36) 0.552
n_bact_md (mean (SD)) 0.50 (0.58) 0.33 (0.71) 0.30 (0.67) 0.88
bact_shift (mean (SD))  − 2.25 (1.89)  − 1.90 (1.37)  − 2.60 (2.22) 0.704
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septic arthritis of the ankle joint after a grade III open frac-
ture, 4 weeks after the injury and 3 weeks after the aug-
mented mesh graft procedure. Due to insufficient healing 
after the Matriderm®-augmented mesh graft, this patient 
required vascular free flap surgery for permanent closure 
of the defect, and due to the ongoing osteomyelitis of the 
ankle joint, subsequently an arthrodesis of the joint became 
necessary. The second case, a patient with severe rheuma-
toid arthritis, presented with a reoccurring wound defect on 
the left lateral malleolus in a chronic osteomyelitis 3.5 years 
after the first Matriderm®-augmented mesh graft procedure. 
A first attempt of revision with Matriderm@-augmented 
skin grafting failed, and the patient subsequently underwent 
free flap surgery with good long-term outcome. The third 
case was a young woman with a severe soft tissue trauma 
to the left thigh sustained in a truck accident. She needed 
revision of the augmented skin graft in a small fraction of 
the initially treated defect about 5 months after the first sur-
gery. She subsequently fully recovered. The last patient, who 
required revision surgery, suffered traumatic amputations of 
both lower legs. He presented with recurrences of the treated 
wounds after 10 months on the right leg and 34 months post-
operatively on the left leg, respectively, which both had to be 
treated with free flap surgery. While the right stump showed 
a good long-term result, the left stump developed ulcers after 
flap surgery, which required long-lasting wound treatment 
by out plastic surgery department, which is still ongoing 
(Winter 2020).
We applied different NPWT systems depending on the 
complexity of the defects. Less complicated defects were 
treated with standard NPWT while more complex defects 
received instillation NPWT (VAC Ultra®). The reasoning 
behind this approach was the assumption of a greater biobur-
den in more complex wounds such as open fractures or obvi-
ously contaminated wounds, therefore aiming to reduce the 
Picture 1  a Left side and b right side: bilateral dermatofasciotomy of 
the lower leg and foot
Picture 2  a Left side and b 
right side: application of Mat-
riderm® 1 mm in combination 
with mesh graft transplantation
Picture 3  a Left side and b right side: right leg 2.5 years after mesh 
graft transplantation with Matriderm™ augmentation
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bioburden by continuous irrigation [17] in addition to sur-
gical debridement. In our opinion, the combined procedure 
with repetitive surgical debridement and negative pressure 
therapy is more efficient and gentler than surgical debride-
ment alone. NPWT stimulates wound healing by improve-
ment of vascularization of the wound bed. The complexity of 
the wounds is also reflected in the duration of VAC therapy 
with open fractures requiring NPWT significantly longer 
compared to closed fractures or soft tissue defects without 
osseous involvement subsequently leading to longer periods 
of hospitalization as well. Also, when comparing the number 
of VAC changes and surgical debridements required prior 
to the skin grafting, patients with open fractures required 
the most procedures before the application of Matriderm®. 
This staged approach aimed at conditioning even the most 
complex wounds in a way that closure with Matriderm®-
augmented skin grafting would become possible in a one-
step approach. In addition to radical and sufficient surgical 
debridement, NPWT played a major role in the precon-
ditioning of wounds as it increases perfusion within the 
wound, accelerates granulation tissue formation, and reduces 
edema as well as the bioburden [18]. With this approach, we 
achieved healing after the first Matriderm®-augmented split 
skin grafting in almost 90% of the cases, even in complex 
wound situations after open fractures. Those positive results 
go hand in hand with those of other research groups, where 
the augmentation with Matriderm® also lead to an improve-
ment in the outcome after the treatment of soft tissue defects 
with low rates of recurrences [2, 21, 23].
With the combination of debridement and NPWT prior 
to the skin grafting, we could further achieve a relevant 
reduction of the bacterial load in the treated defects of all 
three different injury groups, which is in accordance with the 
results of other groups [20, 24–29]. But not all defects were 
free of pathogens when we performed the skin grafting aug-
mented with Matriderm®, which is in stark contrast to the 
methods described by other studies [2, 30]. In nine cases, we 
performed the final wound closure in wounds, which were 
not yet free of pathogens, what did not seem to have a nega-
tive influence on the healing as those patients showed good 
long-term results with a reduced duration of hospitalization 
and number of surgical procedures.
The complexity of the wound also influenced the number 
of different antibiotic substances given to the patients, with 
those with open fractures receiving the highest number of 
different antibiotics.
A surprising result was that the existence of comorbidi-
ties did not have a relevant impact on the outcome, which 
contrasts with the results of other groups [31, 32]. The 
main reason for this discrepancy can be found in the differ-
ent severities of injuries studied. While we mainly treated 
patients with locally limited injuries, the studies mentioned 
above investigated patients with systemic impairments due 
to injuries.
The great advantages of Matriderm® as a product com-
pared to other dermal regeneration substitutes such as the 
dermal regeneration template Integra® (Integra LifeS-
ciences, 1100 Campus Road, Princeton, NJ, 08,540) are 
first of all the possibility of a one-step approach [2, 23] and 
a higher graft take rate [21], which leads to shorter duration 
of hospitalization and a reduction of surgical procedures 
required. Also, compared to much more complex and time-
consuming procedures promoting dermal regeneration such 
as keratinocytes cultures [33], Matriderm® is our preferred 
choice due to time efficiency, costs, and functional out-
come. This also strongly promotes the economic benefit 
of the application of Matriderm® despite its costs [34] 
compared to well-established but long-lasting and com-
plex treatments such as flap surgery, which are associated 
with relevant donor and acceptor side morbidity [35]. Flap 
surgery can result in flap necrosis [36–38] as well as rel-
evant morbidity at the donor side such as scaring [5] mak-
ing it a highly delicate procedure requiring experienced 
microsurgeons. Lack of experienced surgeons or the wound 
conditions themselves may make flap surgery not feasible 
in multiple cases—just as discussed in our case report—
where due to vascular injuries, we had to abstain from flap 
surgery and resort to Matriderm®-augmented split-thick-
ness skin grafting after close consultation with our col-
leagues of the department of plastic surgery. But of course, 
we are aware of the limitations of our Matriderm®-based 
approach and that there are plenty of indications making 
flap surgery mandatory with excellent results in terms of 
functionality and cosmetics [39, 40]. In our experience, 
Matriderm®-augmented split-thickness skin grafts achieve 
high stability and elasticity of soft tissue coverage, which 
is at the outmost importance in situations such as amputa-
tion stump coverage or in defects close to joints. Further-
more, we found—in accordance with other studies—the 
scarring to be much smoother compared to split-thickness 
skin grafting alone with clinically significantly less postop-
erative development of keloids, leading to a higher overall 
patient satisfaction. Ryssel et al. compared autologous skin 
grafts to a combination of Matriderm® matrix and autolo-
gous skin grafts. The combination led to a significantly 
increased elasticity of the newly formed skin after wound 
healing [2, 23, 35]. Furthermore, Min et al. showed that 
areas covered with Matriderm® showed similar qualities in 
terms of skin barrier and skin color to those of the adjacent 
normal skin [23], similar results were presented by Watfa 
et al. also reporting positive results concerning sensory 
function after augmentation of harvest side in transgender 
surgeries with Matriderm® [41]. Synoptically, we there-
fore think that Matriderm®-augmented split skin grafting 
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offers a valid treatment option in many different cases of 
full-thickness wounds and that its indications should be 
expanded and that it should be more frequently used as 
an adjunct to flap surgery in the future, always keeping its 
limitations in mind.
Our retrospective cohort study does have limita-
tions. The main limitation is the fact that our study is 
not of a comparative nature. Therefore, we are not able 
to demonstrate the difference between Matriderm®-
augmented mesh grafts and mesh grafts without aug-
mentation. But in the current literature, it is clearly 
demonstrated that complex traumatic wounds with soft 
tissue defects are frequently showing complications 
in wound healing after regular mesh graft procedures 
without Matriderm® augmentation. Furthermore, we 
included different kinds of wounds and classified them 
as “complex.” But there is no practical classification 
system for the complexity of full-thickness defects, and 
therefore, we based the inclusion of cases on our clini-
cal experience. Nevertheless, we think that our report of 
healing rates of about 90% of cases after Matriderm®-
augmented split skin grafting is still of clinical and sci-
entific benefit.
The main strength of our study is its large cohort of 
traumatic soft tissue defects, which is to our best knowl-
edge one of the largest in the current literature. Further-
more, our investigations are not only limited to the skin 
grafting procedure alone but also involve the process 
of wound conditioning prior to the grafting. Moreover, 
our study covers an extensive follow-up period, which 
allows well-founded statements regarding long-term 
results.
Conclusion
We could demonstrate in this study that Matriderm®-
augmented split-thickness skin grafting leads to gener-
ally good long-term results even in complex wounds 
with a relevant bioburden. The complexity of the wounds 
in terms of injury pattern and bioburden did not have a 
significant impact on the long-term results. In order to 
achieve the best possible outcome, different aspects of 
a wound defect must be taken into consideration and 
an interdisciplinary approach with the involvement of 
trauma, orthopedic, and plastic and vascular surgeons as 
well as interventional radiologist is often required. With 
an individual approach to each wound in terms of wound 
conditioning using NPWT as an adjunct to debridement 
as well as adequate antibiotic treatment, Matriderm®-
augmented split skin grafting allows wound closure in 
a timely and economically highly efficient way even in 
extremely complex defects. Further studies of comparative 
nature between augmented and non-augmented skin grafts 
as well as between Matriderm®-augmented skin grafting 
and flap surgery are needed to further investigate the role 
of Matriderm®-augmented split-thickness skin grafting 
in complex wounds.
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